Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (beta 1-(2-deoxyribopyranosyl))thymidine
2. Deoxyuridine
1. 951-78-0
2. Deoxyuridine
3. Uracil Deoxyriboside
4. Uridine, 2'-deoxy-
5. 2-deoxyuridine
6. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione
7. Deoxyribose Uracil
8. 2'-desoxyuridine
9. Durd
10. 2'-deoxyuridine-1'-d
11. 1-(2-deoxy-beta-d-ribofuranosyl)uracil
12. W78i7ay22c
13. Chebi:16450
14. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
15. Ccris 2832
16. Nsc 23615
17. Desoxyuridine
18. 1-(2-deoxy-beta-d-erythro-pentofuranoxyl)uracil
19. Uracil Desoxyuridine
20. Mfcd00006527
21. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydro-furan-2-yl)pyrimidine-2,4(1h,3h)-dione
22. Dur
23. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-ribofuranosyl)-
24. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-erythro-ribofuranosyl)-
25. Einecs 213-455-7
26. Brn 0024433
27. Unii-w78i7ay22c
28. Nsc-23615
29. 1-(2-deoxy-d-erythro-pentofuranosyl)uracil
30. Uridinie, 2'-deoxy-
31. 2yb0
32. Deoxyuridine [mi]
33. Bmse000320
34. 1-(2-deoxy-beta-d-erythro-pentofuranosyl)uracil
35. Schembl28844
36. Mls001066344
37. 2'-du
38. Chembl353955
39. 2'-deoxyuridine, >=98.5%
40. Amy6955
41. Dtxsid30883621
42. Hms2267d16
43. Zinc155696
44. Hy-d0186
45. S5505
46. Zinc00155696
47. Akos015833069
48. Akos015896792
49. 1-(2-deoxy-ss-d-ribofuranosyl)uracil
50. Ccg-247504
51. Cs-w019820
52. Db02256
53. Ps-7750
54. 1-[(4s,2r,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropyrimidine-2, 4-dione
55. Ncgc00142492-01
56. Smr000112296
57. D0060
58. 1-(2-deoxy-delta-erythro-pentofuranosyl)uracil
59. C00526
60. O10766
61. 951d780
62. Q419140
63. J-700048
64. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)uracil
65. E73b1553-a13a-4989-b045-a589a8f2b9dc
66. 1-(2-deoxy-beta-d-ribofuranosyl)-2,4(1h,3h)-pyrimidinedione
67. 1-(2-deoxy-beta-delta-ribofuranosyl)-2,4(1h,3h)-pyrimidinedione
68. 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-2,4(1h,3h)-pyrimidinedione
69. 1-(2-deoxy-beta-delta-erythro-pentofuranosyl)-2,4(1h,3h)-pyrimidinedione
70. 1-((2r,4s,5r)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1-h-pyrimidine-2,4-dione
71. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione
Molecular Weight | 228.20 g/mol |
---|---|
Molecular Formula | C9H12N2O5 |
XLogP3 | -1.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 228.07462149 g/mol |
Monoisotopic Mass | 228.07462149 g/mol |
Topological Polar Surface Area | 99.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 343 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antimetabolites
Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
19
PharmaCompass offers a list of Deoxyuridine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deoxyuridine manufacturer or Deoxyuridine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deoxyuridine manufacturer or Deoxyuridine supplier.
PharmaCompass also assists you with knowing the Deoxyuridine API Price utilized in the formulation of products. Deoxyuridine API Price is not always fixed or binding as the Deoxyuridine Price is obtained through a variety of data sources. The Deoxyuridine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Deoxyuridine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deoxyuridine, including repackagers and relabelers. The FDA regulates Deoxyuridine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deoxyuridine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Deoxyuridine supplier is an individual or a company that provides Deoxyuridine active pharmaceutical ingredient (API) or Deoxyuridine finished formulations upon request. The Deoxyuridine suppliers may include Deoxyuridine API manufacturers, exporters, distributors and traders.
click here to find a list of Deoxyuridine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Deoxyuridine DMF (Drug Master File) is a document detailing the whole manufacturing process of Deoxyuridine active pharmaceutical ingredient (API) in detail. Different forms of Deoxyuridine DMFs exist exist since differing nations have different regulations, such as Deoxyuridine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Deoxyuridine DMF submitted to regulatory agencies in the US is known as a USDMF. Deoxyuridine USDMF includes data on Deoxyuridine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Deoxyuridine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Deoxyuridine suppliers with USDMF on PharmaCompass.
Deoxyuridine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Deoxyuridine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deoxyuridine GMP manufacturer or Deoxyuridine GMP API supplier for your needs.
A Deoxyuridine CoA (Certificate of Analysis) is a formal document that attests to Deoxyuridine's compliance with Deoxyuridine specifications and serves as a tool for batch-level quality control.
Deoxyuridine CoA mostly includes findings from lab analyses of a specific batch. For each Deoxyuridine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Deoxyuridine may be tested according to a variety of international standards, such as European Pharmacopoeia (Deoxyuridine EP), Deoxyuridine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deoxyuridine USP).